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Abstract  
Lamellar pathology in experimentally-induced equine laminitis associated 
with euglycaemic hyperinsulinaemia is substantial by the acute, clinical phase (~ 48 h 
post-induction). However, lamellar pathology of the developmental, pre-clinical phase 
requires evaluation. The aim of this study was to analyse lamellar lesions both 
qualitatively and quantitatively, 6 h, 12 h and 24 h after the commencement of 
hyperinsulinaemia. Histological and histomorphometrical analyses of lamellar 
pathology at each time-point included assessment of lamellar length and width, 
epidermal cell proliferation and death, basement membrane (BM) pathology and 
leucocyte infiltration. Archived lamellar tissue from control horses and those with 
acute, insulin-induced laminitis was also assessed for cellular proliferative activity by 
counting the number of cells showing positive nuclear immunolabelling for TPX2.  
Decreased SEL width and increased evidence of apoptotic SEL epidermal basal (and 
suprabasal) cells occurred early in disease progression (6 h). Increased cellular 
proliferation in SELs, infiltration of the dermis with small numbers of leucocytes and 
BM damage occurred later (24 h, 48 h). Some lesions, such as narrowing of the SELs, 
were progressive over this time period (6 - 48 h). Cellular pathology preceded 
leucocyte infiltration and BM pathology, indicating that the latter changes may be 
secondary or downstream events in hyperinsulinaemic laminitis. 
 
Keywords: Equine; Hyperinsulinaemia; Histology; Epidermal lamellae; TPX2 
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Introduction  
Equine laminitis is a complex disease in which the lamellar attachment 
between the inner hoof wall and the distal phalanx is compromised. It accounts for up 
to 15% of lameness in the equine population (USDA, 2000). Despite improved 
methods for diagnosis, management and prevention of the condition (Carter et al., 
2009b; Frank, 2009; Geor and Harris, 2009) specific therapies that target the 
underlying pathophysiology of laminitis are limited. The development of efficacious 
treatment options requires a deeper understanding of disease pathogenesis.  
 
Endocrinopathic laminitis, associated with pars pituitary intermedia 
dysfunction and equine metabolic syndrome, is characterised by hyperinsulinaemia in 
both horses and ponies, and this appears to be the key hormonal mechanism 
associated with lamellar failure (Field and Jeffcott, 1989; Geor, 2009; McGowan et al., 
2004; Treiber et al., 2006). However, the exact mechanism by which 
hyperinsulinaemia causes lamellar pathology is unknown. Research on 
endocrinopathic laminitis has been aided by the development of an experimental 
model, which induced laminitis with hyperinsulinaemia, using a prolonged 
euglycaemic, hyperinsulinaemic clamp (p-EHC), within 72 h in ponies and 48 h in 
horses (Asplin et al., 2007; de Laat et al., 2010).  
 
Previous histological assessments of acute, Obel grade 2, insulin-induced 
laminitis in horses and ponies treated with a p-EHC have described secondary 
epidermal lamellar (SEL) lengthening and narrowing, with increased evidence of 
mitotic activity and apoptotic epidermal cells (Asplin et al., 2010; de Laat et al., 
2011b; Obel, 1948). Lesions occurring in the preclinical, developmental phase of this 
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model have not been described. Lamellar inflammation has been reported in the 
developmental phase of the black walnut (BWE) and alimentary carbohydrate 
overload (ACO) experimental models of laminitis (Black et al., 2006; Faleiros et al., 
2011b; Visser, 2008). However, fewer leucocytes were present in the lamellae of 
horses in the clinical phase of insulin-induced (p-EHC) laminitis compared with ACO 
laminitis (de Laat et al., 2011b). This suggests that insulin-induced laminitis involves 
less overt inflammation of the lamellae than alimentary forms of the disease, and 
leucocyte infiltration may not be an early pathogenic lesion. 
 
This study hypothesised that cellular, inflammatory and degradative events 
occur in the lamellae prior to the onset of the clinical signs of laminitis, and that these 
lesions are not identical to those described in other models of the disease. For the 
current study the Standardbred model of p-EHC-induced laminitis (de Laat et al., 
2010) was repeated, with examination of lamellar tissue from earlier time-points, 
prior to the onset of clinical signs. Specifically we aimed to analyse microscopic 
lamellar lesions both qualitatively and quantitatively, 6 h, 12 h and 24 h after the 
commencement of hyperinsulinaemia.  
 
Materials and Methods  
Ethical approval for this work was granted by the Animal Ethics Committee of 
The University of Queensland (SVS/108/09/RIRDC). The horses were monitored by a 
registered veterinarian throughout the study. 
 
Horses 
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Twelve Standardbred geldings (7.3 ± 1.12 years, 440 ± 51.6 kg BW), recently 
retired from racing (< 6 weeks), were used in this study. They were in moderate body 
condition (body condition score: 4.7/9 (Henneke et al., 1983)) with no phenotypic 
indicators (cresty neck score: 0/5 (Carter et al., 2009a)) of insulin resistance (IR). 
Routine haematological and biochemical parameters were measured, as indicators of 
general health status, before and at the conclusion of the experiment. All horses were 
sound on lameness examination and had no evidence of laminitis on clinical and 
radiographic inspection of the feet. Horses were randomly allocated to one of three 
treatment groups: 6 h (n = 4), 12 h (n = 4) and 24 h (n = 4).  
 
The experiment was conducted as six paired replicates over four weeks. The 
subjects were acclimated to the climate-controlled (22.4 ± 0.34 °C) research facility 
and fed moderate-quality lucerne hay and chaff for the 48 h preceding the study. Ad 
libitum access to water and the same food was allowed during the study. Archived 
lamellar samples from horses with acute insulin-induced laminitis (48 h, (n = 4)), and 
matched control (n = 4) horses treated with a balanced electrolyte solution for 48 h, 
were also used for cell proliferation studies (de Laat et al., 2010). The same control 
horse lamellar tissue was used as a reference point for histological examination and 
morphometry. The horses in these control and laminitic groups were of similar age, 
bodyweight, BCS and breed to the horses in the current study and the experimental 
protocols were identical. 
  
Prolonged euglycaemic, hyperinsulinaemic clamp (p-EHC)  
All subjects were given an insulin bolus (45 mIU/kg BW; Humulin-R) 
followed by a combined insulin (6 mIU/kg BW/min) and glucose (variable rate; 50% 
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dextrose) infusion for 6 h, 12 h or 24 h to maintain euglycaemic hyperinsulinaemia, 
using the EHC technique (DeFronzo et al., 1979). Extended-use IV catheters 
(MilaCath) were maintained in right and left jugular veins for the administration of 
the infusions and blood sampling respectively. Blood samples were collected for 
determination of blood glucose (1 mL) and serum insulin (10 mL) concentrations at 0 
h, hourly until 8 h, then four-hourly throughout the infusion period. In addition, three 
samples were collected 10 min apart, to measure blood glucose and serum insulin 
concentrations during a steady state period (< 180 min), which is defined as a 30 min 
period when the glucose infusion rate does not require adjustment.  
 
Blood glucose was measured immediately using a handheld glucometer 
(Accucheck-Go, Roche) previously calibrated for equine blood against the hexokinase 
method (ρc = 0.96) by the authors (de Laat et al., 2010). Serum insulin concentration 
was measured using a validated radio-immunoassay (Coat-a-count, Siemens) with 
insulin-free serum used as the diluent (McGowan et al., 2008; Tinworth et al., 2009). 
Insulin sensitivity (SI) was calculated retrospectively for all horses by measuring the 
amount of glucose metabolised (M) and M per unit of insulin (M-to-I ratio), according 
to standard protocols (Rijnen and van der Kolk, 2003).  
 
Histology and Immunohistochemistry 
At the end of the experiment horses were euthanased and samples of lamellar 
tissue were immediately collected from the dorsal mid-section of the hoof wall. The 
hoof wall was cut into sagittal blocks with a band-saw, and lamellar specimens (5 mm 
x 5 mm) were dissected with a scalpel, rinsed and placed in 10% neutral buffered 
formalin for 24 h. Lamellar specimens were processed routinely for histology, 
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embedded in paraffin wax and sectioned at 5 µm. Sections were stained with 
haematoxylin and eosin (H & E) and mounted on Superfrost Plus slides (Menzel); 
further sections were stained using the periodic acid-Schiff (PAS) method for 
visualisation of basement membranes (BM). 
 
Immunohistochemical staining of formalin-fixed, paraffin-embedded sections 
from all four feet of the 6 h, 12 h and 24 h groups was performed for leucocyte 
identification with a mouse monoclonal macrophage antibody (calprotectin/MAC-387; 
Dako) using the EnVision+ System-HRP (Dako). Antigen retrieval was performed 
with 0.05% Proteinase K (Dako)
 
for 8 min at room temperature (de Laat et al., 2011b). 
Immunolocalisation of proliferating cells was performed in both fore-feet from horses 
treated with a p-EHC for 6 h, 12 h, 24 h and 48 h, and control horses, with a mouse 
monoclonal antibody to the TPX2 protein (TPX2/ab32795; Abcam) using an 
automated stainer and the HRP system (Dako). Antigen retrieval was achieved with a 
digital electric pressure cooker (Menarini Antigen Access Unit), in sodium citrate 
buffer (pH 6; 125 
o
C for 1 min 40 s).  
 
Calprotectin is located in the cytoplasm of neutrophils and on the membrane 
of monocytes (Striz and Trebichavsky, 2004). TPX2 recognises a nuclear protein 
(repp86/p100) associated with cell proliferation in certain tissues, including the 
epithelium (Heidebrecht et al., 2003). Unlike the Ki-67 antigen, a more commonly 
used immunohistochemical proliferation marker, TPX2 does not immunolocalise cells 
in the G1 phase of the cell cycle which avoids over-estimating the number of 
proliferating cells (Heidebrecht et al., 1997; Rudolph et al., 1998). 
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The antibodies have been validated for use in horses by western blot (JPK pers 
comm., Visser, 2008). Primary antibodies were optimally diluted (MAC-387; 1:400, 
TPX2 1:800) in antibody-dilution solution (Dako). Positive control tissues were 
lamellae from a horse with ACO laminitis (MAC-387) and human and equine skin 
(TPX2). Negative controls used mouse IgG in place of the primary antibody. Sections 
were stained (2 x 5 min) with chromagen 3.3’-diaminobenzidine tetrahydrochloride 
(DAB, Dako) followed by nuclear staining with Mayer’s haematoxylin (30 s).  
 
Immunoreactivity was analysed in all sections, blinded, by one of the authors 
(MAD) using image analysis software (ImagePro). Calprotectin immunoreactivity 
was scored using the following scale: 0 = no staining or occasional calprotectin-
positive cell within a vessel lumen; 1 = mild perivascular infiltration of calprotectin-
positive cells into primary dermal lamellar tissue; 2 = moderate, diffuse infiltration of 
calprotectin-positive cells throughout dermal connective tissue; 3 = marked tissue 
infiltration of calprotectin-positive cells with positive staining of SEL basal and 
parabasal cell cytoplasm (de Laat et al., 2011b). 
 
Total TPX2-positive cell counts were made across five consecutive primary 
epidermal lamellae (PELs) in both fore-feet. The length of each PEL was measured 
and it was divided into abaxial and axial halves. The total number of TPX2-positive 
cells in each half of the five PELs was counted to obtain an abaxial, axial and total 
value for each front foot. Cell counts from both fore-feet were averaged to obtain a 
single value for each horse to account for statistical clustering. A subset (40%) of 
tissue sections was measured by a second, blinded author (CCP) to internally validate 
the measurement protocol. 
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Histomorphometry 
H & E and PAS sections from all four feet of all horses were examined via 
light microscopy (Olympus BX-50) by a veterinary pathologist (JPK), who was 
blinded to the group of origin. Measurement of lamellar morphometry was performed 
blinded, by a different author (MAD), after randomisation of the sections. 
Measurements were made on eight, consecutive PELs, using image analysis software 
(ImagePro), for each foot. Total (TPELL) and keratinised PEL lengths (KPELL) were 
measured. The length of ten SELs was measured separately in the abaxial (SELLB) 
and axial (SELLT) halves of each of the eight PELs, for each foot. SEL width (SELW) 
of ten consecutive SELs was also measured on both sides (in the mid-section) of all 
eight PELs for every horse (n = 20). This measurement protocol has been described 
and validated previously (de Laat et al., 2011b). 
 
Statistical analyses  
Inter-rater measurement agreement was analysed with Lin’s concordance co-
efficient (ρc) and Bland-Altman’s limits of agreement (LOA) with random variation 
assessed with Pearson’s correlation co-efficient (r).  An average of forefoot PEL 
measurements was compared to averaged hindfeet within each group using 
Wilcoxon’s t-test. Average fore-feet measurements, total TPX2 counts and 
calprotectin scores were compared between groups using a Kruskal-Wallis ANOVA 
on ranks. Multiple pair-wise comparisons were made with Tukey’s test. SELW was 
correlated against time with Pearson’s correlation co-efficient (r).  TPX2 data was 
compared between the abaxial and axial locations for each group with Wilcoxon’s t-
test. All data are presented as mean ± standard error (se) or median (range). Statistical 
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significance was set at P < 0.05. Statistical analyses were performed using R, version 
2.7.2. 
 
Results  
 
Prolonged euglycaemic, hyperinsulinaemic clamp (p-EHC)  
All subjects remained healthy throughout the experiment with heart rate, 
respiratory rate, rectal temperature and haematological and biochemical parameters 
remaining unchanged from basal values for each group. Lameness was not detected in 
any of the horses. Blood glucose concentrations did not differ between the groups 
either before or during the infusion (Table 1). Basal serum insulin concentrations did 
not differ between groups. Serum insulin concentrations increased (P < 0.05) from 
basal values during the initial 4 h of the infusion and remained elevated (> 800 
µIU/mL) for the remainder of the experiment for all groups (Fig. 1). All of the horses 
were insulin sensitive (Table 1).  
 
Subjective histological assessment  
Lamellar morphology 
Compared with control horses, elongation of the SELs, with tapering of the 
tips, and a reduction in the angle between the SEL and the PEL axis appeared to be 
occurring by 6 h, in treated horses (Fig. 2a, b). The orientation of SEL nuclei had 
changed from the long axis being perpendicular to the BM, to parallel (Fig. 3a, b), and 
remained in this orientation across all time-points. At 12 h, elongation, tapering and 
angulation of the SELs appeared more pronounced, compared with 6 h (Fig. 2c). 
SELs appeared further elongated, tapered and angulated at 24 h, and were frequently 
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difficult to distinguish from each other, except at the axial tips of the PELs (Fig. 2d). 
The SEL nuclei appeared larger, with enlarged nucleoli, and the epithelial cells more 
disorganised. In three of the 24 h horses, there was either slight blebbing of the BM or 
more extensive separation from the epidermal cells at SEL tips of a few PEL (axial) 
tips (Fig. 3d). In the areas of most marked BM separation, nuclear debris and small 
numbers of infiltrating neutrophils were noted within the separated material.  Mild 
dyskeratosis, with minimally increased keratin, was observed in the SEL and PEL of 
some horses at all time-points. Rare keratin pearls were noted in SEL tips of three 
laminitic horses at the 6 h time-point; these were regarded to be chronic, background 
lesions. 
 
Mitotic figures 
Occasional mitotic figures were found in SELs at the axial tips of PELs in 
some sections at 6 h (Table 2). A few mitotic figures were present at the 12 h time-
point, and again noted in SELs at or near the axial tips of PELs (Fig. 3c). Mitotic 
figures were more frequent again at 24 h than at 6 h or 12 h, but remained localised to 
SELs at PEL tips. 
 
Apoptosis 
Cells that appeared to be undergoing apoptosis were noted in most sections at 
6 h, but varied significantly in number between horses (Table 2). These cells were 
identified on the basis of characteristic morphological changes such as rounding, 
shrinkage, hypereosinophilia, cytoplasmic budding (formation of apoptotic bodies, 
some of which contain nuclear fragments), nuclear chromatin condensation and 
fragmentation and phagocytosis by neighbouring epithelial cells (Meyers and 
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McGavin, 2007). There was no evidence of cellular swelling, nuclear changes or 
intra-epithelial inflammation that would characterise necrosis. The apoptotic bodies 
were located in SELs at any point along the length of the PELs in sections from some 
horses, but were concentrated in SELs only at axial tips of the PELs in others (Fig, 
3b). Apoptotic cells were again found in SELs at any point along the length of the 
PELs in the 12 h group, with clustering in SELs at the axial tips of the PELs noted in 
some sections. However, the number of apoptotic bodies or cells appeared decreased 
overall, at this time-point, compared to 6 h. Minimal apoptosis occurred in the 24 h 
group, often in the same microscopic fields where mitotic figures were observed.  
 
Dermal changes 
Myxomatous (fibrillar basophilic) material was seen immediately surrounding 
PEL tips and around blood vessels in both the secondary and primary dermal lamellae 
(SDL, PDL; Fig. 2b, c). Endothelial cells of all blood vessels were swollen. The 
appearance of the dermis was similar at all time-points.  
 
Histomorphometry  
Forefoot TPELL and KPELL was increased compared to the hind-foot in the 
48 h group, whereas only KPELL differed in the 24 h group. Forefoot TPELL and 
KPELL did not differ between groups (Table 3). Neither SELLB nor SELLT was 
different between fore- and hind-feet for any group. The length of the forefoot SELs 
did not differ between control, 6 h, 12 h or 24 h horses at either location, but there 
was a numerical increase in length over time (Table 3). SEL length was only 
increased significantly by the acute phase at 48 h (de Laat et al., 2011b). Identical 
measurement protocols permitted direct comparison of the data between the two 
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studies. SELs were wider in the fore-feet of the 6 h group compared to the hind feet. 
Forefoot SEL width decreased significantly over time (r = -0.92). SELs were wider (P 
< 0.05) in the control and 6 h groups (Fig. 4).  
 
Immunohistochemistry  
TPX2 
Inter-rater variability (Lin’s ρc (lower C.I.) = 0.95 (0.92)) was minimal with 
random variation (r = 0.98) largely accounting for disparity. Bland-Altman’s LOA 
(C.I.) were 4.4 (-72 - 81) which shows that only minor count differences between 
assessors occurred. TPX2-positive nuclei were infrequent in sections from control 
horses, and horses treated with the p-EHC for 6 h and 12 h (Fig. 5). However, TPX2 
expression was increased (P < 0.05) in both the 24 h and 48 h groups when compared 
to all other groups (Fig. 5). TPX2-positive cells were found in SELs along the length 
of the PELs and stained cells undergoing mitosis, as well as other cells with no visible 
mitotic changes (as expected; Fig. 6). The degree of TPX2 immunoreactivity did not 
differ between the abaxial and axial halves of the PEL for any group (Table 2). 
 
Calprotectin 
Median (range) calprotectin score did not differ between control horses and 
any developmental time-point (Table 2). There was no immunoreactivity to 
calprotectin, except for an occasional leucocyte within the vessel lumen, in the hind-
feet of all horses and the fore-feet of the 6 h group (Fig. 6). Only one horse from the 
12 h group showed mild immunoreactivity to calprotectin around primary dermal 
vessels in the right forefoot, while the remaining feet did not react. In the 24 h group, 
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immunolocalisation of calprotectin was restricted to mild perivascular infiltration of 
the PDL tissue in one forefoot of two horses (Fig. 6).  
 
Discussion  
The current study is the first to describe the histopathology of the 
developmental phase of p-EHC-induced laminitis and provides a temporal analysis of 
some key features of the disease. Although significant histomorphometric differences 
in SEL length were not found between the developmental time-points examined in 
this study, SELs were longer by the onset of clinical laminitis at 48 h (de Laat et al., 
2011b). Failure to detect a significant change in the length of the SELs up to 24 h may 
be related to the small sample size or the time-points examined. More marked 
increases in SEL length may occur later in the developmental phase, after the 24 h 
time-point, but examination of time-points between 24 h and 48 h would be required 
to establish this.  
 
Elongation of the SELs may be related to an increase in the number of 
epidermal cells. The increased presence of mitotic figures and TPX2 
immunolocalisation in SELs at 24 h preceded significant increases in length, 
suggesting that increased numbers of epidermal cells contribute to SEL lengthening. 
Alternatively, stretching of the existing epidermal cells may cause, or at least 
contribute to, early increases in SEL length. Hyperinsulinaemia may alter epidermal 
basal cell metabolism which in-turn, may affect the cytoskeleton of SEL cells, 
reducing their ability to withstand normal biomechanical stress on the lamellae. Loss 
of the normal orientation and ovoid shape of basal cell nuclei may also result from 
cytoskeletal compromise. Weakening of basal cells may lead to physical disruption of 
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the basement membrane and further lengthening of the lamellae. Temporal analysis of 
epidermal cell size, shape and number in SELs throughout the developmental phase, 
and at the onset of the clinical phase would be required to determine whether 
stretching or proliferation of cells is predominant. Ultrastructural examination of 
lamellar tissue with electron microscopy during the developmental and acute stages of 
insulin-induced laminitis would also enhance our appreciation of any cytoskeletal 
and/or desmosomal changes that may be occurring.  
 
An interesting finding of the current study was the progressive narrowing of 
SELs throughout the developmental phase, with a significant decrease in SEL width 
occurring between 6 h and 12 h after the onset of hyperinsulinaemia. Narrowing of 
the SELs may be another early indicator of cellular disorganisation and stretching, 
occurring in conjunction with SEL elongation.  Stretching of the epidermal cells, and 
hence SELs, indicates disruption of the normal support for the distal phalanx within 
the hoof capsule, which may be a causative factor for the distal displacement of the 
distal phalanx that accompanies later stages of the disease.  
 
Insulin has mitogenic potential (Myers and White, 1995) and could be the 
primary instigator of the increased cell division occurring in the treated horses. 
Elevated numbers of mitotic figures have been reported in alimentary forms of 
laminitis, not associated with hyperinsulinaemia (Galey et al., 1991). However, many 
different factors can stimulate cellular division and these will not necessarily be 
identical in different forms of laminitis. Potential mitogenic factors include cytokines, 
growth factors, hormones and a wide variety of cellular stressors.  Insulin-like growth 
factor-1 (IGF-1) promotes cell survival through an increase in cell proliferation and a 
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reduction in apoptosis (Pavelic et al., 2007). While IGF-1 levels are unlikely to be 
increased by hyperinsulinaemia, excessive circulating insulin levels may bind the 
IGF-1 receptor and activate the IGF-1 system, favouring cell survival and 
proliferation. Increases in inflammatory cytokines have been demonstrated in both 
ACO and BWE models of laminitis (Belknap et al., 2007; Leise et al., 2011). 
Although their role in hyperinsulinaemic laminitis has not been well defined, pro-
inflammatory cytokines may contribute to increased epidermal cell proliferation. 
 
Evidence of apoptosis was also found to be prevalent following 6 h of 
hyperinsulinaemia, but appeared to decrease later in the developmental stages. 
Electron microscopic evaluation and immunostaining of the lamellae with an early 
marker for apoptosis may support the histological observations made in this study. 
However, current immunolabelling methodologies have not been well validated in the 
horse and further research into appropriate immunolabels is warranted. The stimulus 
for a potential increase in the incidence of apoptosis early in hyperinsulinaemic 
laminitis pathology is unknown.  
 
An increase in apoptosis is not unique to insulin-induced laminitis and has 
been reported in horses with acute, naturally-acquired laminitis (of unstated cause), 
compared with none in normal horses (Faleiros et al., 2004). Hormones, growth 
factors, oxidative stress and TNF-α, among other factors, are known inducers of 
apoptotic cell death (Avogaro et al., 2010; Kiess and Gallaher, 1998). Although 
visceral adipose TNF-α mRNA concentration is similar in both insulin-resistant and 
insulin-sensitive horses (Burns et al., 2010) this may not be reflected in the lamellae 
and lamellar TNF-α concentration during insulin-induced laminitis development has 
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not been investigated. Current data on the redox status of horses during laminitis does 
not support a significant role for reactive oxygen species in disease pathogenesis 
(Keen et al., 2004; Treiber et al., 2009), and markers of oxidative stress have not been 
found to be increased at any developmental time-point of insulin-induced laminitis 
(de Laat et al., 2012). IGF-1 is a known inhibitor of apoptosis and its withdrawal from 
a tissue may induce apoptosis (Kiess and Gallaher, 1998). Potentially, apoptosis may 
increase secondary to this mechanism during hyperinsulinaemia, if insulin binding of 
the IGF-1 receptor reduces tissue IGF-1 concentrations. Furthermore, binding of the 
IGF-1 receptor by insulin during hyperinsulinaemia may result in activation of the 
IGF system and promotion of cell survival, which could account for the reduction in 
apoptosis seen as the study progressed (Chitnis et al., 2008). Studies of the role of 
IGF-1 in laminitis are required to better understand its pathogenic potential.  
 
BM separation in SELs at PEL tips was first identified at 24 h, was not present 
in all sections and in most cases was not a diffuse or severe change. These findings 
suggest that BM separation is a secondary lesion. A lack of extensive BM damage is 
also consistent with reports of minimal metalloproteinase activity in the lamellae 
during the developmental phase of insulin-induced laminitis (de Laat et al., 2011a).  
 
The calprotectin data supports our previous supposition that the insulin-
induction model is associated with a milder inflammatory response than other 
experimental models of laminitis (de Laat et al., 2011b). Less calprotectin 
immunoreactivity was seen at 48 h in the insulin-induction model compared with 
strong calprotectin expression in the lamellar dermis in the acute and developmental 
(18 h and 24 h) phases of ACO laminitis, (de Laat et al., 2011b; Faleiros et al., 2011a; 
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Visser, 2008). The BWE model of laminitis has also been associated with increased 
presence of inflammatory cells in lamellar tissue, which begins as early as 1.5 h 
following induction (Black et al., 2006; Faleiros et al., 2011b). At the 24 h time-point 
of the current study, calprotectin immunolocalisation was limited to being 
perivascular, with only small numbers of leucocytes present in 50% of the horses 
examined. Neutrophils appear to emigrate to the lamellae after pathology is underway 
in hyperinsulinaemic laminitis, which suggests that they respond to pathology, rather 
than initiate it. These findings may be important when selecting appropriate treatment 
modalities for hyperinsulinaemic laminitis. 
 
Conclusions 
Histological evaluation of horses in the pre-clinical phase of insulin-induced 
laminitis showed that significant lamellar histopathology occurs prior to the 
development of clinical signs at 48 h. Overall, structural changes such as SEL 
lengthening and narrowing and some cellular changes, including apoptosis and 
nuclear disorientation, occur earlier in disease progression, whereas mitosis and BM 
dysadhesion appear to be downstream events. Increased cellular proliferation, cellular 
stretching or both, may be associated with significant lengthening of the SELs and 
contribute to lamellar dysfunction and lameness. Prevention of exuberant cell 
proliferation and differentiation may prove to be a potential avenue for disease 
management. 
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Table 1. Three groups of horses (n = 4) were treated with a euglycaemic, 
hyperinsulinaemic clamp for 6 h, 12 h or 24 h. All horses were insulin sensitive.  
Variable 6 h group 12 h group 24 h group 
G basal (mM) 5.3 ± 0.32 5.5 ± 0.14 5.6 ± 0.21 
G clamp (mM) 4.3 ± 0.19 4.1 ± 0.35 4.4 ± 0.21 
I basal (µIU/mL) 10.2 ± 2.95 8.68 ± 1.07 12.0 ± 4.2 
I steady state (µIU/mL) 811 ± 132 977 ± 86 747 ± 41 
M (mmol/kg/min) 0.02 ± 0.003 0.023 ± 0.004 0.021 ± 0.002 
M-to-I ratio (10
-6
) 3.3 ± 0.4 3.2 ± 0.7 3.9 ± 0.2 
Key: G basal: basal glucose concentration, G clamp: blood glucose concentration during 
the clamp, I basal: basal serum insulin, I steady state: serum insulin concentration (I) at 
steady state, M: amount of glucose metabolised and a measure of sensitivity of tissues 
to exogenous insulin, M-to-I ratio: glucose metabolised per unit of exogenous insulin. 
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Table 2: Median (range) TPX2-positive epidermal cell counts in the abaxial and axial 
halves of 5 forefeet PELs and calprotectin score following immunohistochemical 
staining. Calprotectin data for control and 48 h horses is from de Laat et al. (2011). 
Mitotic figures and apoptotic cell counts/hpf in the lamellae of horses treated with a 
prolonged euglycaemic, hyperinsulinaemic clamp for 6 h (n = 4), 12 h (n = 4), 24 h (n 
= 4) or 48 h (n = 4) and a control group (CH, n = 4) treated with a balanced electrolyte 
solution for 48 h.  
Pathology CH 6 h 12 h 24 h 48 h 
TPX2      
Abaxial 
0.5 (0.3 – 
1.8) 
3.9 (2.4 – 
4.3) 
1 (0.75 – 
1) 
63 (39.3 
– 98) * 
159 (87 – 
202) * 
Axial 
5 (2.5 – 
10.5) 
6.5 (1 – 
12.3) 
2.5 (1 – 
5) 
216 (87 – 
454) * 
121 (87 – 
162) * 
Calprotectin      
Fore 0 (0 - 0) 0 (0 - 0) 0 (0 - 0) 
0 (0 – 
0.5) 
1.8 (1 – 
2) * 
Hind 0 (0 - 0) 0 (0 - 0) 0 (0 - 0) 0 (0 - 0) 
0 (0 - 
0.3) 
Mitotic figures/hpf 0 0 0-1 0-5 0-5 
Apoptotic cells/hpf 0 0-15 0-5 0-1 0-2 
Key: TPX2: Immunohistochemical marker of cellular proliferation, hpf: high power 
field (400 X magnification). The asterisks indicate which groups differ (P < 0.05). 
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 Table 3: Median (range) length (µm) of the primary (PELs) and secondary epidermal 
lamellae (SELs) and width of SELs measured in all four feet of horses treated with a 
prolonged euglycaemic, hyperinsulinaemic clamp for 6 h (n = 4), 12 h (n = 4), 24 h (n 
= 4) or 48 h (n = 4) and a control group (CH, n = 4) treated with a balanced electrolyte 
solution for 48 h. Data for control and 48 h horses is from de Laat et al. (2011).  
Parameter CH 6 h 12 h 24 h 48 h 
TPELL      
Fore 
3359 (3008 - 
3663) 
3049 (2894 – 
3418) 
3413 (2956 – 
3651) 
3169 (3100 – 
3299) 
§
 
3384 (3292 – 
3442) 
§
 
Hind 
2766 (2569 – 
3083) 
2724 (2655 – 
2913) 
2953 (2405 – 
3417) 
2672 (2372 – 
2891) 
2750 (2631 – 
2785) 
KPELL      
Fore 
2895 (2750 – 
3180) 
2583 (2320 – 
2854) 
2660 (2533 – 
2868) 
2626 (2089 – 
2717) 
2779 (2677 – 
2843) 
§
 
Hind 
2578 (2346 – 
2962) 
2321 (2250 – 
2503) 
2527 (2160 – 
3666) 
2155 (1967 – 
2477) 
2215 (2195 – 
2256) 
SELLB      
Fore 
142 (107 – 
173) 
176 (149 – 
202) 
177 (164 – 
199) 
190 (168 – 
219) 
226 (213 – 
254) * 
Hind 
130 (117 – 
157) 
228 (174 – 
268) 
171 (131 – 
326) 
135 (120 – 
203) 
198 (175 - 227) 
SELLT      
Fore 116 (77 – 155) 
169 (149 – 
179) 
174 (141 – 
205) 
198 (163 – 
218) 
270 (187 – 
326) 
Hind 
125 (113 – 
130) 
172 (148 – 
184) 
157 (113 – 
308) 
161 (109 – 
211) 
216 (201 – 
232) 
SELW      
Fore 
25 (21.5 – 
28.5) * 
25.2 (22.5 – 
26.1) *
§
 
19.9 (16.2 - 
20.2) 
20.2 (19 – 
20.7) 
12.3 (10.8 – 
15) 
Hind 23 (20 – 25) 
18 (17.9 – 
19.5)  
21.2 (19.7 – 
22.3) 
17.7 (15.9 – 
18.8) 
15.8 (11.5 – 
22) 
Key: TPELL: total primary epidermal lamellar length, KPELL: keratinised primary 
epidermal lamellar length, SELLB: secondary epidermal lamellar length (abaxial end 
of the PEL), SELLT: secondary epidermal lamellar length (axial end of the PEL), 
SELW: secondary epidermal lamellar width in the mid-section of the PEL. * indicates 
forefoot parameters that differ (P < 0.05) between groups. 
§ 
indicates if
 
forefeet differ 
(P < 0.05) to the hind-feet within each group. 
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Fig. 1. Mean serum insulin concentration (µIU/mL) of three groups of horses (n = 4) 
treated with a euglycaemic, hyperinsulinaemic clamp for 24 h (●), 12 h (∆) and 6 h 
(▒). Serum insulin increased (P < 0.05) from basal levels over the first 4 h of the 
infusion and remained elevated for the remainder of the experiment.  
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Fig. 2. Photomicrographs of the axial ends and entire length (insets) of primary 
epidermal lamellae (PELs), with attached secondary epidermal lamellae (SELs). a; 
control horse (48 h), b; 6 h time-point. There are changes in the lamellar morphology 
relative to the control horse in terms of elongation, narrowing and tapering of the 
SELs. Myxomatous (basophilic) material is present around dermal blood vessels. c; 
12 h time-point. Subjectively, there is further elongation of SEL. Myxomatous 
material (arrow) is still present at this time-point, around now dilated blood vessels in 
the dermis. d; 24 h time-point, with similar changes to those noted at 12 h. 
Haematoxylin and eosin. Bar = 100 µm. 
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Fig. 3.  Photomicrographs of secondary epidermal lamellae (SELs) at the axial tips of 
PELs. a; control horse with long axes of the nuclei of basal SEL cells (arrow) oriented 
perpendicularly to the basement membrane (BM). b; 6 h time-point, with increased 
numbers of apoptotic cells (arrows). Long axes of many nuclei of SEL basal cells are 
now oriented parallel to the BM. b inset; two of the apoptotic bodies have been 
phagocytosed by epithelial cells, the nuclei of which are slightly compressed (arrows). 
c; 12 h time-point, with infrequent mitotic figures (arrow). d; 24 h time-point with 
blebbing i.e. slight separation of the BM from tips of the SELs (arrows). The inset 
shows one such “bleb”, creating a clear space at the SEL tip; the arrow indicates the 
BM. e; 24 h time-point with more advanced, complete separation of the BM from 
SEL tips (arrows). a, b, c = Haematoxylin and eosin. Bar = 50 µm. d = Periodic acid-
Schiff (PAS). Bar = 50 μm. e =PAS. Bar = 100 µm.  
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Fig. 4. Secondary epidermal lamellar (SEL) width (µm) in horses treated with a 
euglycaemic, hyperinsulinaemic clamp for 6 h (n = 4), 12 h (n = 4), 24 h (n = 4) and 
48 h (n = 4) and control horses (CH, n = 4) treated with a balanced electrolyte 
solution for 48 h. Median SEL width (―) is shown for each group. SELs were wider 
(P < 0.05) in control horses and those treated for 6 h than all other groups. Data for 
control and 48 h horses from de Laat et al. (2011). 
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Fig. 5. Immunolocalisation of a cellular proliferative marker, TPX2, was increased (P 
< 0.05) in the PELs of horses treated with a euglycaemic, hyperinsulinaemic clamp 
for 24 h (n = 4) and 48 h (n = 4), compared to those treated for 12 h (n = 4) and 6 h (n 
= 4), and normal control horses (CH; n = 4). The median TPX2-positive cell count (―) 
is shown for each group. 
 
  
 32 
Fig. 6. Photomicrographs of the axial tips of secondary epidermal lamellae (SEL) 
from horses treated with a euglycaemic, hyperinsulinaemic clamp for 6 h (a, b) and 24 
h (c, d) stained immunohistochemically with TPX2 (a, c) and calprotectin (b, d). 
TPX2 stains cells undergoing mitosis (arrowhead), as well as other cells with no 
visible mitotic changes (arrows). Fewer (P < 0.05) proliferating epidermal cells were 
seen in horses treated for 6 h (a) compared with 24 h (c). Immunolocalisation of 
calprotectin failed to highlight significantly increased numbers of infiltrating 
leucocytes after 6 h (b) or 24 h (d) of hyperinsulinaemia.   
 
 
